M. Capra

Publication List Details

Period

2004 - 2007

Number

9

Co-Authors

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia (2006)

Cappellini, M.D., Cohen, A., Piga, A., Bejaoui, M., Perrotta, S., Agaoglu, L., ...

Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3 trial was conducted to demonstrate the...

Interweaving mobile games with everyday life (2006)

Bell, M., Chalmers, M., Barkhuus, L., Hall, M., Sherwood, S., Tennent, P., ...

We introduce a location--based game called Feeding Yoshi that provides an example of seamful design, in which key characteristics of its underlying technologies-the coverage and security...

Interweaving mobile games with everyday life

Bell, M., Chalmers, M., Barkhuus, L., Hall, M., Sherwood, S., Tennent, P., ...

We introduce a location--based game called Feeding Yoshi that provides an example of seamful design, in which key characteristics of its underlying technologies-the coverage and security...

Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia.

Di Marco, V, Lo Iacono, O, Capra, M, Grutta, S, Ciaccio, C, Gerardi, C, ...

In this open, pilot study, interferon (IFN) alpha-2b seemed effective in the treatment of hepatitis C virus (HCV) infection in patients with beta-thalassaemia. In seven of nine patients who completed...

Interweaving mobile games with everyday life

Bell, M., Chalmers, M., Barkhuus, L., Hall, M., Sherwood, S., Tennent, P., ...

We introduce a location--based game called Feeding Yoshi that provides an example of seamful design, in which key characteristics of its underlying technologies-the coverage and security...

Hypothyroidism and polyneuropathy.

Beghi, E, Delodovici, M L, Bogliun, G, Crespi, V, Paleari, F, Gamba, P, ...

The prevalence and characteristics of polyneuropathy were assessed using standard clinical and electrophysiological criteria in 39 consecutive outpatients with primary hypothyroidism, 15 of whom were...